Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Market Cap	1.36B -18.1%
Revenue (ttm)	n/a -11.7%
Net Income	n/a
EPS	n/a
Shares Out	103.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.11 (0.85%)
Ex-Dividend Date	Dec 17, 2025

Volume	215,044
Average Volume	644,311
Open	n/a
Previous Close	13.00
Day's Range	13.00 - 13.50
52-Week Range	11.10 - 18.50
Beta	0.22
RSI	33.34
Earnings Date	Apr 28, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 313
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILCOPHL

Financial Performance

In fiscal year 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.